Research Team Receives $7 Million Funding Award to Study Most Effective Way of Sharing Clinic Visit Information with Older Adults
A Dartmouth-led research group, including investigators from Vanderbilt University Medical Center, University of Texas Medical Branch and Harvard Medical School, has received a $7 million funding award from the Patient-Centered Outcomes Research Institute to compare the effectiveness of sharing clinic visit information via a patient portal versus an audio recording with older adults and caregivers. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - July 26, 2022 Category: Hospital Management Authors: Timothy Dean Tags: News Research Paul Barr PCORI Source Type: news
Boston recruit to lead new University of Texas School of Public Health San Antonio
The founding dean brings an impressive track record in grant funding to the Alamo City. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 25, 2022 Category: American Health Authors: W. Scott Bailey Source Type: news
‘Gold mine of unexplored biology’: Short protein sequences could dramatically expand human genome
The relatively small universe of human genes could grow by up to one-third, if a concerted effort to search for new genes that encode short proteins is successful. Many known miniproteins have already been shown to play key roles in cellular metabolism and disease, so the international effort to catalog new ones and determine their functions, announced last week in
Nature Biotechnology
, could shed light on a vast array of biochemical processes and provide targets for novel medicines.
“The microproteome is a potential gold mine of unexplored biology,” says Eric Olson, a molecular biologist at the Univer...
Source: ScienceNOW - July 21, 2022 Category: Science Source Type: news
The SEVEN healthy habits that may almost halve your risk of suffering a stroke
University of Texas researchers found people following seven habits had a dramatically lower chance of stroke than those who didn't. The study tracked more than 11,500 middle-aged adults. (Source: the Mail online | Health)
Source: the Mail online | Health - July 20, 2022 Category: Consumer Health News Source Type: news
Alzheimer ’s disease detectives at UT Health San Antonio find more needles in the haystack
21 million. That ’s the number of genetic variations in the human genome that researchers are sifting to identify patterns predisposing people to Alzheimer’s disease.
With international collaboration being advanced by faculty of The University of Texas Health Science Center at San Antonio, also known as UT Heal th San Antonio, more genetic variations for Alzheimer’s disease are known today than ever before. The list of gene variants recognized for late-onset Alzheimer’s grew from one in 2009… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 1, 2022 Category: American Health Authors: UT Health San Antonio Source Type: news
Researchers discover new leukemia-killing compounds
Researchers from Rice University and the University of Texas MD Anderson Cancer Center have discovered potential new drugs that work in concert with other drugs to deliver a deadly one-two punch to leukemia.
The potential drugs are still years away from being tested in cancer patients, but a recently published study in the journal Leukemia highlights their promise and the innovative methods that led to their discovery. (Source: World Pharma News)
Source: World Pharma News - June 30, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
One Class at a Texas University Dodges the Financial Burden of Med School
(MedPage Today) -- Last week, Fort Worth's Texas Christian University (TCU) School of Medicine announced that the Class of 2024 received a financial gift from an anonymous donor that fully covers tuition for the next academic year, marking the... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 24, 2022 Category: American Health Source Type: news
Beyond argumentum in terrorem: the contested rhetoric of campus carry - Butters AM.
This essay reflects on the use of competing rhetorical frames of fear strategically used by the academic community of The University of Texas at Austin in the debate on Campus Carry policy. With the legalization of concealed handguns on campus, fear emerge... (Source: SafetyLit)
Source: SafetyLit - June 21, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Not a "nonissue": perceptions and realities of campus carry at the University of Texas at Austin - Ruoppila S, Butters AM.
As a publicly funded institution,The University of Texas at Austin had to implement the state's legislation to allow concealed handguns on campus. Yet its own Campus Carry policy has sought to erase the matter from everyday campus life. The administration ... (Source: SafetyLit)
Source: SafetyLit - June 21, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Table of Experts: The new cancer quest and what it means for San Antonio
The objective of the discussion is to better understand what is driving value in cancer care, to examine… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 17, 2022 Category: American Health Source Type: news
UT Health partnership with global digital prosthetics company helps boost workflow
At University of Texas Health Science Center's School of Dentistry, a lab's partnership with an international digital prosthetics company — and a brand-new technology for taking molds — has improved workflow during the pandemic.
A new style of automated milling equipment for creating crowns and performing other dental restorations, called the Matik and manufactured by Austria-based digital prosthetics company Amann Girrbach AG, uses computer-aided manufacturing software that can mill any dental… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 10, 2022 Category: Biotechnology Authors: Donna Provencher Source Type: news
Fewer Than Half of U.S. Pharmacies Carry One of the Most Effective Drugs for Opioid Abuse
Today’s illicit drug supply is riskier than ever, experts say. It’s often contaminated by different dangerous substances—from the potent opioid fentanyl, to the horse tranquilizer xylazine, to benzodiazepines—which makes using illegal drugs more unpredictable and raises the risk of overdose.
These risks make effective treatments indispensable. However, one of the most successful treatments for opioid dependence—buprenorphine—is difficult to get at most pharmacies across the country, according to a new study published in the journal Drug and Alcohol Dependence.
Researchers conducted secre...
Source: TIME: Health - June 10, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized Addiction healthscienceclimate Source Type: news
New Insights Into Better Immunotherapy; Diabetes and Cancer; Skin Cancer Advice
(MedPage Today) -- In preclinical studies, a small-molecule activator of lymphocyte function-associated antigen 1 showed potential for transforming "cold" tumors into "hot" ones that are more responsive to immunotherapy. (University of Texas MD... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 8, 2022 Category: Hematology Source Type: news
Phase 3 SHINE Results Show IMBRUVICA ® (ibrutinib)-Based Combination Regimen Significantly Reduced the Risk of Disease Progression or Death in Older Patients with Newly Diagnosed Mantle Cell Lymphoma
This study is one of the largest clinical trials ever conducted in first-line MCL and the first for a Bruton’s tyrosine kinase inhibitor (BTKi).[1] The data are being presented in an oral session and featured in a press briefing during the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, and were published in The New England Journal of Medicine today. The data will also be presented as an oral presentation at the 2022 European Hematology Association (EHA) Annual Congress. MCL is a type of aggressive, rare non-Hodgkin lymphoma (NHL) that is incurable and difficult to treat.[2] It commonly affects people o...
Source: Johnson and Johnson - June 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
San Antonio researchers study how restraining a liver enzyme could help us trim down, reduce appetite
Scientists with The University of Texas Health Science Center at San Antonio, also called UT Health San Antonio, noted weight loss and decreased appetite in obese mice treated with a novel investigational therapy. The team reported findings in the high-impact journal Cell Metabolism this spring.
The therapy slows liver enzyme activity, which leads to appetite control in the brain and increased energy expenditure in fat cells. The researchers are in UT Health San Antonio’s Sam and Ann Barshop Institute… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 1, 2022 Category: Pharmaceuticals Authors: UT Health San Antonio Source Type: news
